Video

About Ovarian Cancer

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Breaking Down The Use of Rina-S in Advanced Ovarian Cancer
Image of woman.
Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer
Sue Friedman in an interview with CURE
More Is Needed to Connect Clinicians, Patients to Clinical Trials
Elahere Symptoms Patients With Ovarian Cancer Should Look Out For
Elahere Symptoms Patients With Ovarian Cancer Should Look Out For
Dr. Alex Francoeur interviewing against a gray CURE background
Palliative Care Decreases Hospital Readmissions in Ovarian Cancer
What Patients and Their Families Should Know About Hereditary Breast Cancer
What Patients and Their Families Should Know About Hereditary Breast Cancer
Support is ‘Critical’ for Those Affected By Hereditary Cancers
Support is ‘Critical’ for Those Affected By Hereditary Cancers
Making Strides and Breaking Down Barriers in Genetic Testing for Breast Cancer
Making Strides and Breaking Down Barriers in Genetic Testing for Breast Cancer
The Value of Partnerships for Hereditary Cancers
The Value of Partnerships for Hereditary Cancers
Clinical Trials in Hereditary Cancer Maybe A Key to Better Health Outcomes
Clinical Trials in Hereditary Cancer Maybe A Key to Better Health Outcomes
Related Content
Image of ovary.
May 8th 2025

The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer

Ryan Scott
The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of ovary.
May 2nd 2025

First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer

Ryan Scott
The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.
Shannon Miller smiling at a podium while delivering the keynote address at the 2023 Extraordinary Healer event | Image credit: © ATA-GIRL PHOTOGRAPHY
May 4th 2023

Olympian Shares Her Cancer Experience: ‘Give Yourself Grace’

Brielle Benyon
Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.
Rendering of an ovary with a tumor
April 7th 2025

BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer

Alex Biese
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
Illustration of ovaries.
April 3rd 2025

Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted

Alex Biese
A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.